Literature DB >> 8336821

Effects of blockade of AT1 and AT2 receptors in brain on the central angiotensin II pressor response in conscious spontaneously hypertensive rats.

G M Toney1, J P Porter.   

Abstract

Intracerebroventricular (i.c.v.) administration of angiotensin II (ANG II) increases vascular resistance and arterial pressure by increasing the activity in the sympathetic nervous system (SNS-component) and secretion of vasopressin (VP-component). This study examined the role of AT1 and AT2 receptors in brain in mediating the exaggerated central cardiovascular effects of ANG II in conscious, adult (10 weeks) spontaneously hypertensive rats (SHR). Mean arterial pressure, heart rate and renal blood flow responses to intraventricular injection of ANG II (100 ng in 5 microliters) were determined 10 min after intraventricular administration of the AT1 receptor antagonist losartan alone (1.0, 2.5, 5.0, 10.0 micrograms), the AT2 receptor ligand PD 123319 alone (3.5 x [10(-6), 10(-4), 10(-2), 10(0)] micrograms), or both ligands in combination. In control rats, intraventricular administration of losartan prevented the pressor and renal vascular resistance responses to intraventricular injection of ANG II, in a dose-dependent manner (P < 0.05), while intraventricular injection of PD 123319 was ineffective. Likewise, when the SNS- and VP-components were studied individually by preventing the VP-component with a V1 receptor antagonist (i.v.) or the SNS-component with chlorisondamine (i.v.), losartan (i.c.v.) prevented both components, while PD 123319 (i.c.v.) was without affect. In addition, doses of losartan, combined with 3.5 micrograms PD 123319, were no more effective in preventing the pressor or renal vascular resistance responses than losartan, administered alone, suggesting that the VP- and SNS-components of the pressor response to ANG II (i.c.v.) are mediated primarily by AT1 receptors in brain in conscious spontaneously hypertensive rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8336821     DOI: 10.1016/0028-3908(93)90054-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Increased expression of angiotensin II type 2 receptors in the solitary-vagal complex blunts renovascular hypertension.

Authors:  Graziela Torres Blanch; André Henrique Freiria-Oliveira; Guilherme Fleury Fina Speretta; Eduardo J Carrera; Hongwei Li; Robert C Speth; Eduardo Colombari; Colin Sumners; Débora S A Colombari
Journal:  Hypertension       Date:  2014-06-23       Impact factor: 10.190

Review 2.  Protective Angiotensin Type 2 Receptors in the Brain and Hypertension.

Authors:  Annette D de Kloet; Ulrike M Steckelings; Colin Sumners
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

3.  Role of phosphatidylinositol 3-kinase in angiotensin II regulation of norepinephrine neuromodulation in brain neurons of the spontaneously hypertensive rat.

Authors:  H Yang; M K Raizada
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

4.  High salt intake enhances swim stress-induced PVN vasopressin cell activation and active stress coping.

Authors:  N C Mitchell; T L Gilman; L C Daws; G M Toney
Journal:  Psychoneuroendocrinology       Date:  2018-04-06       Impact factor: 4.905

5.  Repeated administration of angiotensin II reduces its dipsogenic effect without affecting saline intake.

Authors:  Peter J Vento; Derek Daniels
Journal:  Exp Physiol       Date:  2010-03-12       Impact factor: 2.969

6.  Hypotensive and sympathoinhibitory responses to selective central AT2 receptor stimulation in spontaneously hypertensive rats.

Authors:  Sofie Brouwers; Ilse Smolders; Richard D Wainford; Alain G Dupont
Journal:  Clin Sci (Lond)       Date:  2015-07       Impact factor: 6.124

7.  Differential regulation of the renin-angiotensin system by nicotine in WKY and SHR glia.

Authors:  Merari F R Ferrari; Mohan K Raizada; Debora R Fior-Chadi
Journal:  J Mol Neurosci       Date:  2008-03-28       Impact factor: 3.444

8.  A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH.

Authors:  Miroslava Macova; Jaroslav Pavel; Juan M Saavedra
Journal:  Brain Res       Date:  2008-11-12       Impact factor: 3.252

Review 9.  Compromised blood-brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension.

Authors:  V C Biancardi; J E Stern
Journal:  J Physiol       Date:  2015-12-21       Impact factor: 5.182

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.